Plumb Pharmaceuticals has developed a platform technology for the extended release of medications into a patient’s system. Their first product will focus on improving opioid addiction treatment by doubling the release time of naltrexone. Plumb has refined two key formulations using a rat model and plans to move testing into a dog model before the end of the year. They are currently in the early stages of opening their next fundraising round.
Location: United States, Wisconsin, Madison
Investors 1
| Date | Name | Website |
| - | Winnow Fun... | winnowfund... |
Mentions in press and media 1
| Date | Title | Description |
| 18.04.2024 | gener8tor Madison invests $600K into six new startups | MADISON, Wis. – Six new fast-growing startup companies from across the country have each been selected to receive a $100,000 investment and participate in the gener8tor Madison startup accelerator program. The capital invested in this cohor... |